Trial intelligence / Profile preview

Exparel vs Marcaine for Pain Management Following Total Knee Arthroplasty

NCT02060591Unknown

Sponsor
Rothman Orthopaedics
Start
Jan 2014
Primary completion
Jan 2015
Modality
Small Molecules
Countries
1
01

Overview

Trial of bupivacaine in postoperative pain (2 arms), sponsored by Rothman Orthopaedics. Primary endpoint: Visual Analogue Scale for Pain at 30 days. Status: unknown.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02060591.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02060591.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call